Planned BIOA (BIOA) Nasdaq stock sale totals 7,433 common shares

Rhea-AI Filing Summary

A shareholder associated with BIOA has filed a notice under Rule 144 to sell 7,433 shares of common stock through Fidelity Brokerage Services LLC on 02/02/2026 on the NASDAQ. The filing lists an aggregate market value of $139,368.75 for this planned sale and notes 35,855,037 shares of the same class outstanding.

The shares to be sold were acquired by exercising stock options granted on 07/01/2020 and 05/29/2022, with 5,433 and 2,000 shares, respectively, paid for in cash on 02/02/2026. The shareholder also sold common shares in the last three months, including 68,897 shares on 12/04/2025, 18,000 shares on 12/09/2025, and 7,433 shares on 01/02/2026, for stated gross proceeds in each case.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7433	139368.75	35855037	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2026	Option Granted - 07/01/2020	Issuer			5433	02/02/2026	Cash
Common	02/02/2026	Option Granted - 05/29/2022	Issuer			2000	02/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paul Rubin 5885 Hollis St Suite 370 Emeryville CA 94608	Common	12/04/2025	68897	701911.75
Paul Rubin 5885 Hollis St Suite 370 Emeryville CA 94608	Common	12/09/2025	18000	216000.00
Paul Rubin 5885 Hollis St Suite 370 Emeryville CA 94608	Common	01/02/2026	7433	95490.42

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BIOA Form 144 filing disclose about planned share sales?

The Form 144 filing discloses a planned sale of 7,433 BIOA common shares through Fidelity Brokerage Services LLC on 02/02/2026. The filing lists an aggregate market value of $139,368.75 and indicates trading will occur on the NASDAQ exchange.

How many BIOA shares are outstanding according to this Form 144?

The filing states that 35,855,037 BIOA common shares are outstanding. This number provides context for the planned sale of 7,433 shares under Rule 144 and helps investors gauge the relative size of the transaction versus the total share count.

How were the BIOA shares being sold under Rule 144 acquired?

The BIOA shares were acquired by exercising stock options granted on 07/01/2020 and 05/29/2022. The shareholder obtained 5,433 and 2,000 shares, respectively, paying cash on 02/02/2026. These option exercises created the common shares now subject to the planned sale.

What recent BIOA share sales are reported for the same shareholder?

The filing lists prior BIOA common stock sales over three months: 68,897 shares on 12/04/2025, 18,000 shares on 12/09/2025, and 7,433 shares on 01/02/2026. Each transaction includes stated gross proceeds, showing an ongoing pattern of share dispositions.

Which broker will handle the planned BIOA share sale under this Form 144?

The planned BIOA share sale will be handled by Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The transaction involves selling 7,433 common shares on the NASDAQ exchange, with the market value disclosed in the filing.

What representation does the seller make about BIOA information in this Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about BIOA’s current or prospective operations that has not been publicly disclosed. This representation is a standard requirement when submitting a Rule 144 notice of proposed sale.